1. Introduction {#sec1-medicina-54-00026}
===============

Recently, the number of cases with aortic pathology has increased markedly, which has resulted in the search for conservative surgical treatment methods \[[@B1-medicina-54-00026],[@B2-medicina-54-00026],[@B3-medicina-54-00026]\]. Consequently, new minimally invasive approaches (e.g., upper and lower ministernotomy; V-shaped, Z-shaped, T-shaped, J-shaped sternotomy; and other types of ministernotomy) have been introduced \[[@B4-medicina-54-00026],[@B5-medicina-54-00026],[@B6-medicina-54-00026]\]. New ministernotomy techniques have improved the treatment and reduced the incidence of perioperative complications compared with the full sternotomy \[[@B2-medicina-54-00026],[@B3-medicina-54-00026],[@B4-medicina-54-00026],[@B5-medicina-54-00026],[@B6-medicina-54-00026]\].

Currently, a number of studies comparing short-term and long-term results of full sternotomy and minimally invasive techniques have been conducted for hemisternotomy \[[@B7-medicina-54-00026],[@B8-medicina-54-00026],[@B9-medicina-54-00026]\]. Minimally invasive approaches reduced the amount of blood loss, probability of infection and hospitalization duration; improved cosmetic results; and accelerated patient recovery \[[@B10-medicina-54-00026],[@B11-medicina-54-00026],[@B12-medicina-54-00026],[@B13-medicina-54-00026]\]. Despite the numerous advantages inherent to minimally invasive techniques, some authors have noted several negative effects, such as longer aortic cross-clamp and cardiopulmonary bypass times \[[@B12-medicina-54-00026],[@B13-medicina-54-00026],[@B14-medicina-54-00026]\], which could in turn influence surgery performance and could be an unfavorable factor for patients of advanced age \[[@B15-medicina-54-00026],[@B16-medicina-54-00026]\]. Moreover, some studies have explored short-term survival outcomes of minimally invasive techniques as compared with those of full sternotomy. Byrne et al. and Tabata et al. suggest that ministernotomy limits the invasiveness of surgical interventions, which may reduce morbidity \[[@B17-medicina-54-00026],[@B18-medicina-54-00026]\]. They argue that ministernotomy avoids unnecessary lower mediastinal dissection leading to reduced blood loss, need for transfusion, and length of stay in the critical care unit and in the hospital. Using a larger series of procedures (1126 patients), Totaro et al. investigated the perioperative mortality arising from re-do procedures, isolated first-time aortic valve replacement, and complex procedures. Their findings demonstrated that minimal invasion may be particularly useful in patients undergoing complex re-do surgical procedures \[[@B19-medicina-54-00026]\].

In this study, we present our experience with ministernotomy. The aim of our study was to analyze and compare operative, early postoperative outcomes, long-term postoperative results and 5-year survival after aortic valve replacement through ministernotomy and full sternotomy. The study is unique in the sense that we perform a comprehensive comparison of the outcomes of the two procedures over a longer period than previous studies and all the possible influences of the type of access on the patient's health.

2. Materials and Methods {#sec2-medicina-54-00026}
========================

This is a retrospective study of patients who underwent isolated aortic valve replacement through sternotomy or ministernotomy. All operations were performed between 1 October 2011 and 1 January 2016 in the department of cardiovascular medicine, Vilnius University Hospital Santaros Klinikos. From 2011 to 2016, 426 cardiac interventions were performed, of which 70 (16.4%) were minimal access surgery and 356 (83.6%) were interventions by means of a longitudinal sternotomy. Permission to conduct the study was obtained from Vilnius Regional Biomedical Research Ethics Committee (No. 158200-14-715-235).

The patients were selected according to age, sex, body mass index, etiology of the underlying disease, diagnosis, New York Heart Association (NYHA) evaluation, and echocardiographic parameters. To reduce selection bias, we used propensity score matching. Both the ministernotomy and full sternotomy (control) groups had 70 patients each. Patients requiring reoperation and procedures such as coronary artery bypass grafting, surgery of mitral or other valves, ascending aorta replacement, atrial fibrillation ablation, or aortic valve plasty were excluded from the study.

Statistical Analysis
--------------------

Evaluation of dichotomous variables was done using the Fisher exact test, and the data are presented as percentages and number of cases. Categorical data were analyzed using the chi-square test. Continuously distributed variables were evaluated using the Student t test and presented as the mean ± standard deviation. The Shapiro--Wilk test was applied to check the normality of distribution of our data. Five-year survival was evaluated using Kaplan--Meier analysis and compared statistically using the log rank test. To reduce selection bias, a propensity score was calculated for each patient by logistic regression. A multinomial propensity score-matched cohort was constructed by nearest neighbor matching without replacement. Statistical analysis were performed using the Statistical Package for Social Sciences, version 21.0 (SPSS, Chicago, IL, USA), and *p* \< 0.05 was considered statistically significant.

3. Results {#sec3-medicina-54-00026}
==========

The number of males was slightly higher than that of females in full sternotomy and ministernotomy (54.2% and 60%, respectively). Overall, the sternotomy patients were slightly older with a mean age of 61.04 ± 11.9 years than the ministernotomy patients with a mean of 60.8 ± 11.4 years (*p* = 0.155). However, the difference in age of patients in full sternotomy and ministernotomy was not significant. [Table 1](#medicina-54-00026-t001){ref-type="table"} illustrates the significant preoperative characteristics for the minimal invasive and full sternotomy patients. The characteristics between the groups were similar before surgery; however, EuroSCORE II \>3% occurred more frequently in the sternotomy group than in the ministernotomy group (*p* = 0.006 in the overall cohort, *p* = 0.049 in the propensity matched cohort). A majority of patients were NYHA Class III in both conventional sternotomy as well as in ministernotomy in both cohorts. There were 81.43% NYHA Class III in the mini-sternotomy group and 84.6% in the sternotomy group in the overall cohort. In the propensity score matched cohort, there were 81.43% in the ministernotomy group and 91.4% in the sternotomy group. Analysis of comorbidity showed that the ministernotomy group had more patients with hypertension than the sternotomy group (*p* = 0.003, *p* = 0.016 respectively). Chronic obstructive pulmonary disease (COPD) was significantly more frequent in patients with minimally invasive access (4 (5.7%), *p* = 0.042); COPD was not observed in the full sternotomy group.

[Table 2](#medicina-54-00026-t002){ref-type="table"} presents the intraoperative characteristics of both groups. In the overall cohort, a statistical difference in operative time was noted (*p* = 0.037). Ministernotomy had longer cross clamp (88.7 ± 20.7 vs. 79.9 ± 24.8 min, *p* \< 0.001) and bypass (144.0 ± 29.9 vs. 132.7 ± 44.5 min, *p* = 0.026) times. Biological and mechanical valve type were used in the ministernotomy and sternotomy. There was a significant difference in the number of patients in whom a biological or mechanical valve was used in both the overall cohort and PSM cohort (*p* \< 0.001).

In the propensity matched cohort, no statistical difference in operative time was noted (*p* = 0.856). The ministernotomy required significantly longer aortic cross-clamping time (8 min longer) than that required for the sternotomy (*p* = 0.007). The ministernotomy also required longer cardiopulmonary bypass time, which lasted almost 12 min longer than that in the full sternotomy (*p* = 0.049). Repeated cardioplegia was performed in 3 (4.3%) patients from the sternotomy group, but was not applied to the ministernotomy group (*p* = 0.080).

Postoperative statistics ([Table 3](#medicina-54-00026-t003){ref-type="table"}) show that the ministernotomy had a few advantages over the full sternotomy. In the overall cohort, there was a lower incidence of 30-day mortality, of 1.4% in the ministernotomy group and 3.7% in the full sternotomy group (*p* = 0.022), a lower incidence of repeated cardioplegia, *p* = 0.042, shorter hospital stay post-surgery (17.6 ± 16.9 vs.13.06 ± 1.0 *p* = 0.025), and less 24-h chest tube drainage, *p* \< 0.001.

In the propensity matched cohort, the duration of mechanical ventilation was significantly shorter during the ministernotomy than the full sternotomy (9.7 ± 1.7 h vs. 11.7 ± 1.4 h, *p* = 0.001). The amount of blood flowing through the chest tube drainage in the ministernotomy was almost 1.5 times more than that in the full sternotomy (*p* \< 0.001). The total duration of hospitalization in the full sternotomy group was almost 4 days longer than that of the ministernotomy group (*p* = 0.012). Fourteen patients (20%) in the full sternotomy group underwent a correction of coagulopathy; no correction of coagulopathy was performed in the ministernotomy group (*p* \< 0.001). Moreover, an evaluation of drug therapy for hemodynamic support showed that catecholamine is used significantly more often in the full sternotomy group than in the ministernotomy group (30.0% vs. 5.71%, *p* \< 0.001). Evaluation of the use of pain medication showed that morphine is used significantly more often during the full sternotomy than during the mini-sternotomy (98.57% vs. 90.00%, *p* = 0.029). Stroke in both groups was not observed after surgery.

The analysis of factors predicting mortality after aortic valve replacement have shown that there is a strong correlation between left ventricular ejection fraction (LVEF) and the requirement of correction for coagulopathy. Patients with LVEF between 30--49% and with need for correction of coagulopathy have high chances of death as compared to patients with LVEF between \>50% and with no requirement for correction of coagulopathy, as shown in [Table 4](#medicina-54-00026-t004){ref-type="table"}.

Based on a patient satisfaction survey, a significant increase in satisfaction after the ministernotomy was found, which could be attributed to a faster return to activities of daily living and better cosmetic results ([Figure 1](#medicina-54-00026-f001){ref-type="fig"}, [Figure 2](#medicina-54-00026-f002){ref-type="fig"} and [Figure 3](#medicina-54-00026-f003){ref-type="fig"}). Except for eating, there was a higher percentage of patients with mini-sternotomy surgery compared to full sternotomy patients, who can cough, breathe, walk a short distance and brush their teeth by themselves. There were no patients with a surgical wound in the ministernotomy, while most patients in the sternotomy group felt discomfort because of their postoperative wounds. The results of the survey about the cosmetic effects of both methods in the propensity matching cohort are shown in [Figure 3](#medicina-54-00026-f003){ref-type="fig"}.

To evaluate the long-term results of the operations, echocardiographic parameters, NYHA stages, and clinical symptoms were examined for 3 years. After 1 year, the number of patients without complaints was significantly greater in the ministernotomy group (*n =* 61) 60 (98.4%) than in the full sternotomy group (*n =* 57) 46 (80.7%) (*p* = 0.002). During this period, no new cardiac interventions were performed, and on the second and third year of observation, significant differences in echocardiographic parameters, NYHA stage, and clinical symptoms between groups were not observed.

Thus, the major differences between the two operational techniques were observed in the early postoperative period. We found that the differences between groups decreased in the long term. Moreover, our findings were confirmed by the analysis using the Kaplan--Meier methodology ([Figure 4](#medicina-54-00026-f004){ref-type="fig"} and [Figure 5](#medicina-54-00026-f005){ref-type="fig"}). In the overall cohort, the 5-year survival of the ministernotomy group was 91.3% while that in the full sternotomy group was 97.4% (*p* = 0.582) [Figure 4](#medicina-54-00026-f004){ref-type="fig"}. In the propensity matched cohort, the 5-year survival: 66 (94.3%) in the ministernotomy group, 67 (95.7%) in the sternotomy group, total 133 (95%). The log-rank test revealed no significant differences in survival between the groups (*p* = 0.659) [Figure 5](#medicina-54-00026-f005){ref-type="fig"}.

4. Discussion {#sec4-medicina-54-00026}
=============

In this study, the evaluation of the results of the full sternotomy and the ministernotomy for aortic valve replacement revealed that the duration of the ministernotomy is longer than that of the full sternotomy. However, no statistical difference was observed in the propensity score matched cohort. We found that the ministernotomy requires a longer time to clamp the aorta during surgery and a longer cardiopulmonary bypass time. These results are consistent with previous findings \[[@B10-medicina-54-00026]\]. Glauber et al. \[[@B9-medicina-54-00026]\] and Lim et al. \[[@B14-medicina-54-00026]\] reported that aortic valve replacement via a ministernotomy could be performed safely, despite the longer ischemic time. This fact is confirmed in the works of the majority of authors, which can worsen the parameters of the operation as a whole, and also become a particularly unfavorable factor for elderly patients. Nevertheless, opposite favorable tendencies were reported in some studies. In a retrospective analysis of the treatment of 2103 patients who underwent primary, isolated aortic valve replacement (ministernotomy approach (*n =* 936); full sternotomy approach (*n =* 1167)), Shehada et al. demonstrated that the time of aorta clamping during the operation was not statistically different between the full sternotomy and ministernotomy \[[@B11-medicina-54-00026]\]. Their study showed that 30-day mortality for the ministernotomy and full sternotomy are not significantly different; their study advocated that the ministernotomy is a safe and effective procedure associated with a low mortality rate and good long-term survival rates. In addition to that, the ministernotomy was associated with shorter ventilation times, a lower rate of autologous blood transfusion, as well as a lower rate of postoperative respiratory and renal insufficiency.

When assessing postoperative indices, we found that the ventilation time during the ministernotomy was significantly shorter than that during the full sternotomy, which is also comparable with the results of other studies \[[@B20-medicina-54-00026],[@B21-medicina-54-00026]\]. Moreover, we noted a smaller amount of bleeding in the first 24 h after surgery through the chest tube drainage in the ministernotomy group. In the work of Yilmaz et al. \[[@B21-medicina-54-00026]\], the amount of blood loss was also significantly less during the ministernotomy. After a ministernotomy, a significantly smaller number of patients needed medical correction of coagulopathy. Hence, the small amount of blood volume loss during the ministernotomy not only could contribute to a more rapid patient recovery but also has a significant economic implication, i.e., in relation to the medications for the correction of coagulopathy.

The duration of hospitalization was almost 4 days longer in the full sternotomy group. Similar results are found in several studies comparing the ministernotomy and full sternotomy \[[@B10-medicina-54-00026],[@B12-medicina-54-00026],[@B21-medicina-54-00026]\]. A shorter hospitalization duration is one of the main advantages of most minimally invasive methods. Furthermore, a comparison of the frequency of postoperative complications, such as postoperative wound infections, atrial fibrillation, cardiac tamponade, embolism, and acute renal failure, revealed no significant differences between the groups. Similar results were found in a previous meta-analysis \[[@B9-medicina-54-00026]\].

Based on the survey, patient satisfaction with the ministernotomy increased, which could be attributed to a faster return to activities of daily living and better cosmetic results. Several authors have demonstrated an improved cosmetic appearance of the postoperative wound after a ministernotomy \[[@B9-medicina-54-00026],[@B11-medicina-54-00026],[@B12-medicina-54-00026]\]. Nevertheless, patient satisfaction in relation to a small incision lies not only in the better postoperative wound appearance but also in decreased pain intensity during breathing and the activities of daily living. Amr \[[@B12-medicina-54-00026]\] also wrote about this in his study, and noted that in the early hospital period patients after a J-shaped upper ministernotomy could freely breathe without restrictions to their physical activity. Another important advantage of a small incision is the prevention of sternal wound dehiscence or overriding edges. A smaller wound contributes to a more rapid patient recovery \[[@B9-medicina-54-00026]\]. Moreover, a year after the operation, the number of patients without complaints associated with their underlying disease and surgical intervention was significantly higher in the ministernotomy group; however, during the follow-up at 3 years, the difference was no longer statistically significant.

According to the results obtained in our study over a 5-year period, the differences between the groups were no longer statistically significant in the long term, which was confirmed by the Kaplan--Meier analysis. No significant differences in the 5-year survival between the groups were observed. Similar results were obtained by Skripochnik et al. \[[@B22-medicina-54-00026]\]; in assessing 1- and 4-year survival, they noted no significant differences between patients in the mini-invasive and those in full access groups. However, Merk et al. reported higher 5- and 8-year survival rates in patients who underwent minimal access operation than in those who underwent traditional interventions \[[@B20-medicina-54-00026]\]. Although the authors could not explain this unique finding, they suggested that it could be due to the fact that the surgeons in the institution under investigation had more experience in performing surgery by minimal access.

This study has some limitations: the retrospective nature of the study, the single center experience, the limited number of study patients, and the fact that preoperative matching between the two groups could have been assessed only with larger groups. Nevertheless, preoperative characteristics were comparable between group ministernotomy and group sternotomy. Another limitation in this study was the lack of standardized recommendations for discharging patients after ministernotomy surgery.

5. Conclusions {#sec5-medicina-54-00026}
==============

Based on our findings, aortic valve replacement with the minimally invasive approach can be sufficiently safe and effective. Surgeries with the said approach reduce the duration of hospitalization, ventilation time, blood loss, surgical trauma and corrections of coagulopathy, improve cosmetic results, and speed up patient rehabilitation and the resumption of normal activities.
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medicina-54-00026-t001_Table 1

###### 

Preoperative patients' characteristics.

  Indicator                          Overall Cohort   Propensity Score Matched Cohort                                             
  ---------------------------------- ---------------- --------------------------------- ------------ -------------- ------------- -------
  Age, mean ± SD, years              60.8 ± 11.6      63.3 ± 13.2                       0.155        60.8 ± 11.6    61.4 ± 11.9   0.155
  Male, *n* (%)                      42 (60.0)        193 (54.2)                        0.384        42 (60)        42 (60)       1.000
  Height, mean ± SD, cm              170.8 ± 10.0     169.3 ± 10.2                      0.247        170.8 ± 10.0   170.1 ± 9.0   0.247
  Body weight, mean ± SD, kg         82.3 ± 1.8       82.6 ± 1.8                        0.886        82.3 ± 1.8     81.0 ± 1.6    0.886
  BMI, mean ± SD, kg/m^2^            27.7 ± 4.4       28.8 ± 5.6                        0.656        27.7 ± 4.4     27.9 ± 4.5    0.536
  Diagnosis, *n* (%)                                                                                                              
  Aortic stenosis                    51 (72.9)        267 (75.2)                        0.822        51 (72.9)      45 (64.3)     0.754
  Aortic regurgitation               12 (17.1)        50 (14.1)                         0.502        12 (17.1)      13 (18.6)     0.825
  Combined                           7 (10.0)         38 (10.7)                         0.763        7 (10.0)       12 (17.1)     0.217
  Etiology of the disease, *n* (%)                                                                                                
  Senile degeneration                53 (75.71)       283 (80.4)                        0.350        53 (75.71)     53 (75.71)    1.000
  Annular expansion                  13 (18.6)        47(13.4)                          0.238        13 (18.6)      12 (17.14)    0.825
  Mitral valve                       1 (1.4)          0 (0.0)                           0.024        1 (1.4)        0 (0.0)       0.316
  Infective endocarditis             3 (4.3)          22 (6.3)                          0.538        3 (4.3)        5 (7.14)      0.466
  EuroSCORE II                                                                                                                    
  \<1%, *n* (%)                      24 (34.3)        99 (27.8)                         0.253        24 (34.3)      20 (28.6)     0.466
  1--3%, *n* (%)                     44 (62.9)        201 (56.5)                        0.344        44 (62.9)      42 (60.0)     0.728
  \>3%, *n* (%)                      2 (2.9)          56 (15.7)                         0.004        2 (2.9)        8 (11.4)      0.049
  NYHA functional class, *n* (%)                                                                                                  
  II                                 12 (17.14)       41 (11.5)                         0.192        12 (17.14)     6 (8.6)       0.130
  III                                57 (81.43)       301 (84.6)                        0.514        57 (81.43)     64 (91.4)     0.084
  IV                                 1 (1.4)          14 (3.9)                          0.299        1 (1.4)        0 (0.0)       0.316
  Creatinine clearance (mL/min)                                                                                                   
  \<50, *n* (%)                      41 (58.6)        3 (0.8)                           0.144        41 (58.6)      36 (51.4)     0.396
  50--85, *n* (%)                    27 (38.6)        196 (55.4)                        0.075        27 (38.6)      31 (44.3)     0.493
  \>85, *n* (%)                      2 (2.86)         155 (43.8)                        0.098        2 (2.86)       3 (4.3)       0.649
  Diabetes mellitus, *n* (%)         11 (15.7)        5 (7.1)                           0.111        11 (15.7)      5 (7.1)       0.111
  COPD, *n* (%)                      4 (5.7)          0 (0.0)                           0.042        4 (5.7)        0 (0.0)       0.042
  Hypertension, *n* (%)              22 (31.4)        57 (16.1)                         0.003        22 (31.4)      10 (16.0)     0.016
  Stroke, *n* (%)                    0 (0.0)          16 (4.5)                          0.086        0 (0.0)        2 (2.9)       0.154
  Coronary artery disease, *n* (%)   3 (4.3)          12 (3.4)                          0.723        3 (4.3)        1 (1.4)       0.310
  Renal failure, *n* (%)             2 (2.9)          1 (1.4)                           0.5590.000   2 (2.9)        1 (1.4)       0.559
  Pacemaker, *n* (%)                 5 (7.1)          16 (4.5)                          1.000        5 (7.1)        2 (2.9)       0.245
  LVEF %, *n* (%)                                                                                                                 
  \<30%                              0 (0.0)          0 (0.0)                           ND           0 (0.0)        0 (0.0)       ND
  30--49%                            16 (22.9)        11 (15.7)                         0.580        16 (22.9)      11 (15.7)     0.284
  ≥50%                               54 (77.1)        59 (84.3)                         0.826        54 (77.1)      59 (84.3)     0.284

LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association Functional Classification; BMI, body mass index; EuroSCORE II, European System for Cardiac Operative Risk Evaluation, version II. ND, not determined.

medicina-54-00026-t002_Table 2

###### 

Characteristics of surgery in the two groups.

  Indicator                                               Overall Cohort   Propensity Score Matched Cohort                                           
  ------------------------------------------------------- ---------------- --------------------------------- --------- -------------- -------------- ---------
  Surgery duration, mean ± standard deviation (SD), min   246.7 ± 74.2     263.5 ± 62.0                      0.037     256.9 ± 79.7   263.5 ± 62.0   0.856
  Aortic cross-clamping time, mean ± SD, min              79.9 ± 24.8      88.7 ± 20.7                       \<0.001   80.3 ± 24.6    88.7 ± 20.7    0.007
  Cardiopulmonary bypass time, mean ± SD, min             132.7 ± 44.5     144.0 ± 29.9                      0.026     132.9 ± 44.9   144.0 ± 29.9   0.049
  Repeated cardioplegia, *n* (%)                          11 (3.1)         0 (0.0)                           0.224     3(4.3)         0 (0.0)        0.080
  Valve type, *n* (%)                                                                                                                                
  Biological                                              163 (45.8)       60 (85.7)                         \<0.001   24 (34.3)      60 (85.7)      \<0.001
  Mechanical                                              193 (54.2)       10 (14.3)                         \<0.001   46 (65.7)      10 (14.3)      \<0.001
  Size of aortic valve prosthesis, *n* (%)                                                                                                           
  19 mm                                                   1 (0.3)          0 (0.0)                           0.657     0 (0.0)        0 (0.0)        ND
  21 mm                                                   57 (16.0)        4 (5.6)                           0.025     7 (10.0)       4 (5.7)        0.346
  23 mm                                                   154 (43.3)       34 (47.2)                         0.549     36 (51.4)      33 (47.1)      0.612
  25 mm                                                   111 (31.2)       30 (41.7)                         0.095     19 (27.1)      29 (41.4)      0.075
  27 mm                                                   31 (8.7)         4 (5.6)                           0.404     8 (11.4)       4 (5.7)        0.227
  29 mm                                                   2 (0.6)          0 (0.0)                           0.530     0 (0.0)        0 (0.0)        ND

ND, not determined.

medicina-54-00026-t003_Table 3

###### 

Postoperative outcomes.

  ------------------------------------------------------------------------------------------------------------------------------------------------------
  Indicator                                      Overall Cohort   Propensity Score Matched Cohort                                             
  ---------------------------------------------- ---------------- --------------------------------- ---------- --------------- -------------- ----------
  Ventilation time, mean ± SD, h                 11.7 ± 17.0      9.7 ± 1.7                         0.213      11.7 ± 1.4      9.7 ± 1.7      \<0.001

  Blood loss ≥1000 mL/24 h, *n* (%)              27 (7.6)         1 (1.4)                           0.069      2 (2.9)         1 (1.4)        0.559

  24-h chest tube drainage, mean± SD, mL         411.9 ± 294.6    256.2 ± 28.6                      \<0.001    407.6 ± 40.37   256.2 ± 28.6   \<0.001

  Coagulopathy correction, *n* (%)               87 (24.4)        0 (0.0)                           \<0.001    14 (20.0)       0 (0.0)        \<0.001

  Blood product transfusion, *n* (%)\            78 (21.9)\       12 (17.1)\                        0.265\     15 (21.4)\      12 (17.1)\     0.520\
  Packed red blood cells\                        7 (2.0)\         4 (5.7)\                          0.096\     1 (1.4)\        4 (5.7)\       0.172\
  Platelet concentrates\                         29 (8.1)         1 (1.4)                           0.041      5 (7.1)         1 (1.4)        0.095
  Fresh frozen plasma                                                                                                                         

  ICU stay, mean ± SD, h                         83.8 ± 124.8     68.97 ± 6.3                       0.305      88.41 ± 20.62   68.97 ± 6.3    0.319

  Hospital stay, mean ± SD, days                 21.9 ± 18.2      18.3 ± 1.9                        0.109      21.9 ± 1.9      18.3 ± 1.9     0.012

  Hospital stay after surgery, mean ± SD, days   17.6 ± 16.9      13.06 ± 1.0                       0.025      15.2 ± 1.5      13.06 ± 1.0    0.113

  30-day mortality, *n* (%)                      13 (3.7)         1 (1.4)                           0.022      0(0.0)          1 (1.4)        0.316

  Resternotomy, *n* (%)                          21 (6)           0 (0.0)                           \<0.001    2(2.9)          1 (1.4)        0.559

  Endocarditis, *n* (%)                          18 (5.1)         1 (1.4)                           0.384      5(7.1)          1 (1.4)        0.095

  Wound infection, *n* (%)                       19 (5.3)         2 (2.9)                           0.645      2(2.9)          2 (2.9)        1,000

  Cardiac tamponade, *n* (%)                     15 (4.2)         1 (1.4)                           0.489      1(1.4)          1 (1.4)        1.000

  Acute renal failure, *n* (%)                   28 (7.9)         2 (2.9)                           0.067      1(1.4)          2 (2.9)        0.559

  Other actions, *n* (%)\                        2 (0.6)\         1 (1.4)\                          0.108\     0 (0.0)\        1 (1.4)\       0.428
  ECMO\                                          16 (4.5)         0 (0.0)                           0.054      0 (0.0)         0 (0.0)        
  IABP                                                                                                                                        

  Cardiac rhythm at discharge\                   18 (5.1)\        3 (4.3)\                          0.071\     3 (4.3)\        3 (4.3)\       1.000\
  New atrial fibrillation, *n* (%)\              12 (3.4)         3 (4.3)                           0.902      4 (5.71)        3 (4.3)        0.698
  New pacemaker, *n* (%)                                                                                                                      

  Number of patients treated with:\              21 (30.0)\       4 (5.71)\                         \<0.001\   21(30.0)\       4 (5.71)\      \<0.001\
  Catecholamine, *n* (%)\                        350 (98.31)      63 (90.0)                         0.042      69 (98.57)      63 (90.0)      0.029
  Morphine, *n* (%)                                                                                                                           

  Morphine dose, mean ± SD, mg                   18.56 ± 17.08    8.33 ± 3.58                       \<0.001    18.56 ± 17.08   8.33 ± 3.58    \<0.001

  LVEF% at discharge, *n* (%)\                   7 (2.1)\         0 (0.0)\                          0.732\     0 (0.0)\        0 (0.0)\       ND\
  \<30%\                                         49 (14.7)\       12 (17.4)\                        0.427\     13 (18.6)\      12 (17.4)\     0.856\
  30%--49%\                                      278 (83.2)       57 (82.6)                         0.428      57 (81.4)       57 (82.6)      0.856
  ≥50%                                                                                                                                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------

ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection fraction; ND, not determined.
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###### 

Factors predicting mortality in patients undergoing aortic valve replacement.

  Variables                                       Relative Risk (RR)   95% CI          *p* Value
  ----------------------------------------------- -------------------- --------------- -----------
  Preop hypertension (no vs. yes)                 1.717                0.320--9.209    0.528
  Preop LVEF (30--49% vs. \>50%)                  0.156                0.031--0.774    0.023
  Aortotomy (transverse vs. J-shaped)             0.761                0.124--4.668    0.768
  Type of cardioplegia                                                                 
  (coronary ostium vs. both)                      1.326                0.156--11.301   0.796
  (retrograde vs. both)                           0.140                0.006--3.494    0.231
  Aortic valve type (biological vs. mechanical)   1.059                0.154--7.303    0.953
  Coagulopathy correction (no vs. yes)            7.412                1.046--52.508   0.045
